Radiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Published online before print August 17, 2007, 10.1148/radiol.2451070353
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
2451070353v1
245/1/168    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Collidge, T. A.
Right arrow Articles by Roditi, G. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Collidge, T. A.
Right arrow Articles by Roditi, G. H.
(Radiology 2007;245:168-175.)
© RSNA, 2007

Genitourinary Imaging

Gadolinium-enhanced MR Imaging and Nephrogenic Systemic Fibrosis: Retrospective Study of a Renal Replacement Therapy Cohort1

Tara Anne Collidge, MBChB, PhD, MRCP, Peter Campbell Thomson, MBChB, BSc(MedSci), MRCP, Patrick Barry Mark, MBChB, BSc(MedSci), MRCP, James Phillip Traynor, MBChB, MD, MRCP, Alan George Jardine, MBChB, MD, FRCP, Scott Thomas William Morris, MBChB, PhD, FRCP, Keith Simpson, MBChB, FRCP, and Giles Hannibal Roditi, MBChB, FRCP, FRCR

1 From the Renal Unit (T.A.C., P.C.T., S.T.W.M., K.S.) and Radiology Department (G.H.R.), Glasgow Royal Infirmary, Castle Street, 3rd Floor Walton Bldg, Glasgow G4 0SF, Scotland; and Renal Unit, Level 7, Western Infirmary, Glasgow, Scotland (P.B.M., J.P.T., A.G.J.). Received February 20, 2007; revision requested March 20; revision received April 2; accepted April 16; final version accepted May 2. Address correspondence to P.C.T. (e-mail: peter.thomson{at}northglasgow.scot.nhs.uk).

Purpose: To retrospectively compare the frequency of administration and cumulative dose of gadolinium-based contrast agent in dialysis-dependent patients who did and those who did not develop nephrogenic systemic fibrosis.

Materials and Methods: The ethics committees granted exempt status for this study and also waived the need for informed consent. A retrospective analysis was performed of all adult patients undergoing dialysis in the west of Scotland between January 1, 2000, and July 1, 2006. Diagnoses of nephrogenic systemic fibrosis, episodes of gadolinium-enhanced magnetic resonance (MR) imaging, and cumulative doses of gadolinium-based contrast agent were recorded. Outcomes were analyzed by means of parametric and nonparametric testing.

Results: Fourteen of 1826 patients had a diagnosis of nephrogenic systemic fibrosis. Mortality was similar for affected and nonaffected patients. Thirteen (93%) of 14 patients with nephrogenic systemic fibrosis had undergone gadolinium-enhanced MR imaging compared with 408 (22.5%) of 1812 nonaffected patients (P < .001). Patients with nephrogenic systemic fibrosis received a higher median cumulative dose of gadodiamide (0.39 vs 0.23 mmol per kilogram of body weight, P = .008) and underwent more gadolinium-enhanced MR imaging than their nonaffected gadolinium-exposed counterparts.

Conclusion: The data support a positive association between gadolinium-based contrast agent administration and development of nephrogenic systemic fibrosis in the established renal failure population; in addition, there is a positive association between cumulative dose of gadodiamide used and dosing events.

© RSNA, 2007




This article has been cited by other articles:


Home page
 Nephrol Dial TransplantHome page
I. Boehm
Which laboratory parameters are characteristic for nephrogenic systemic fibrosis?
Nephrol. Dial. Transplant., July 1, 2009; 24(7): 2293 - 2293.
[Full Text] [PDF]

Home page
 Am. J. Roentgenol.Home page
M. F. Morris, Y. Zhang, H. Zhang, J. C. Prowda, D. N. Silvers, R. A. Fawwaz, and M. R. Prince
Features of Nephrogenic Systemic Fibrosis on Radiology Examinations
Am. J. Roentgenol., July 1, 2009; 193(1): 61 - 69.
[Abstract] [Full Text] [PDF]

Home page
 Nephrol Dial TransplantHome page
R. Agarwal, S. M. Brunelli, and C. A. Umscheid
Reply
Nephrol. Dial. Transplant., July 1, 2009; 24(7): 2293 - 2294.
[Full Text] [PDF]

Home page
 Am. J. Roentgenol.Home page
M. D. Bridges, B. S. St. Amant, R. B. McNeil, J. G. Cernigliaro, J. P. Dwyer, and P. M. Fitzpatrick
High-Dose Gadodiamide for Catheter Angiography and CT in Patients With Varying Degrees of Renal Insufficiency: Prevalence of Subsequent Nephrogenic Systemic Fibrosis and Decline in Renal Function
Am. J. Roentgenol., June 1, 2009; 192(6): 1538 - 1543.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Roentgenol.Home page
F. W. Roemer, A. Guermazi, Y. Zhang, M. Yang, D. J. Hunter, M. D. Crema, and K. Bohndorf
Hoffa's Fat Pad: Evaluation on Unenhanced MR Images as a Measure of Patellofemoral Synovitis in Osteoarthritis
Am. J. Roentgenol., June 1, 2009; 192(6): 1696 - 1700.
[Abstract] [Full Text] [PDF]

Home page
 RadiologyHome page
M. Anzidei, A. Napoli, B. C. Marincola, I. Nofroni, D. Geiger, F. Zaccagna, C. Catalano, and R. Passariello
Gadofosveset-enhanced MR Angiography of Carotid Arteries: Does Steady-State Imaging Improve Accuracy of First-Pass Imaging? Comparison with Selective Digital Subtraction Angiography
Radiology, May 1, 2009; 251(2): 457 - 466.
[Abstract] [Full Text] [PDF]

Home page
 Clin RiskHome page
G. Roditi
MRI contrast agent safety in renal impairment
Clin Risk, March 1, 2009; 15(2): 47 - 53.
[Full Text] [PDF]

Home page
 Nephrol Dial TransplantHome page
R. Agarwal, S. M. Brunelli, K. Williams, M. D. Mitchell, H. I. Feldman, and C. A. Umscheid
Gadolinium-based contrast agents and nephrogenic systemic fibrosis: a systematic review and meta-analysis
Nephrol. Dial. Transplant., March 1, 2009; 24(3): 856 - 863.
[Abstract] [Full Text] [PDF]

Home page
 CJASNHome page
M. A. Perazella
Current Status of Gadolinium Toxicity in Patients with Kidney Disease
Clin. J. Am. Soc. Nephrol., February 1, 2009; 4(2): 461 - 469.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Roentgenol.Home page
F. Poschenrieder, O. W. Hamer, T. Herold, T. Schleicher, I. Borisch, S. Feuerbach, and N. Zorger
Diagnostic Accuracy of Intraarterial and IV MR Angiography for the Detection of Stenoses of the Infrainguinal Arteries
Am. J. Roentgenol., January 1, 2009; 192(1): 117 - 121.
[Abstract] [Full Text] [PDF]

Home page
 RadiologyHome page
A. Tomasian, N. Salamon, D. G. Lohan, M. Jalili, J. P. Villablanca, and J. P. Finn
Supraaortic Arteries: Contrast Material Dose Reduction at 3.0-T High-Spatial-Resolution MR Angiography--Feasibility Study
Radiology, December 1, 2008; 249(3): 980 - 990.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Roentgenol.Home page
P. H. Kuo
NSF-Active and NSF-Inert Species of Gadolinium: Mechanistic and Clinical Implications
Am. J. Roentgenol., December 1, 2008; 191(6): 1861 - 1863.
[Full Text] [PDF]

Home page
 RadiologyHome page
J. C. Weinreb
Which Study When? Is Gadolinium-enhanced MR Imaging Safer than Iodine-enhanced CT?
Radiology, October 1, 2008; 249(1): 3 - 8.
[Full Text] [PDF]

Home page
 Am. J. Roentgenol.Home page
F. G. Shellock and A. Spinazzi
MRI Safety Update 2008: Part 1, MRI Contrast Agents and Nephrogenic Systemic Fibrosis
Am. J. Roentgenol., October 1, 2008; 191(4): 1129 - 1139.
[Abstract] [Full Text] [PDF]

Home page
 RadiologyHome page
M. R. Prince, H. Zhang, M. Morris, J. L. MacGregor, M. E. Grossman, J. Silberzweig, R. L. DeLapaz, H. J. Lee, C. M. Magro, and A. M. Valeri
Incidence of Nephrogenic Systemic Fibrosis at Two Large Medical Centers
Radiology, September 1, 2008; 248(3): 807 - 816.
[Abstract] [Full Text] [PDF]

Home page
 RadiologyHome page
R. Wertman, , BA, E. Altun, D. R. Martin, D. G. Mitchell, J. R. Leyendecker, R. B. O'Malley, D. J. Parsons, E. R. Fuller III, and R. C. Semelka
Risk of Nephrogenic Systemic Fibrosis: Evaluation of Gadolinium Chelate Contrast Agents at Four American Universities
Radiology, September 1, 2008; 248(3): 799 - 806.
[Abstract] [Full Text] [PDF]

Home page
 StrokeHome page
M. G. Lansberg, V. N. Thijs, R. Bammer, J.-M. Olivot, M. P. Marks, L. R. Wechsler, S. Kemp, and G. W. Albers
The MRA-DWI Mismatch Identifies Patients With Stroke Who Are Likely to Benefit From Reperfusion
Stroke, September 1, 2008; 39(9): 2491 - 2496.
[Abstract] [Full Text] [PDF]

Home page
 RadiologyHome page
N. M. Rofsky, A. D. Sherry, and R. E. Lenkinski
Nephrogenic Systemic Fibrosis: A Chemical Perspective
Radiology, June 1, 2008; 247(3): 608 - 612.
[Full Text] [PDF]

Home page
 RadiologyHome page
Y. Tsushima, A. Takahashi-Taketomi, and K. Endo
Nephrogenic Systemic Fibrosis in Japan: Advisability of Keeping the Administered Dose as Low as Possible
Radiology, June 1, 2008; 247(3): 915 - 916.
[Full Text] [PDF]

Home page
 CJASNHome page
M. A. Perazella
How Should Nephrologists Approach Gadolinium-based Contrast Imaging in Patients with Kidney Disease?
Clin. J. Am. Soc. Nephrol., May 1, 2008; 3(3): 649 - 651.
[Full Text] [PDF]

Home page
 ImagingHome page
L R Williams, M J Oldale, and A J Bradley
Imaging renal masses and staging renal tumours
Imaging, March 1, 2008; 20(1): 73 - 86.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Roentgenol.Home page
W. M. Shabana, R. H. Cohan, J. H. Ellis, H. K. Hussain, I. R. Francis, L. D. Su, S. K. Mukherji, and R. D. Swartz
Nephrogenic Systemic Fibrosis: A Report of 29 Cases
Am. J. Roentgenol., March 1, 2008; 190(3): 736 - 741.
[Abstract] [Full Text] [PDF]

Home page
 Arch OphthalmolHome page
A. Kahana, M. J. Lucarelli, A. M. Grayev, J. J. Van Buren, C. N. Burkat, and L. R. Gentry
Noninvasive Dynamic Magnetic Resonance Angiography With Time-Resolved Imaging of Contrast KineticS (TRICKS) in the Evaluation of Orbital Vascular Lesions
Arch Ophthalmol, December 1, 2007; 125(12): 1635 - 1642.
[Abstract] [Full Text] [PDF]

Home page
 JWatch GeneralHome page
Nephrogenic Systemic Fibrosis: A Presumed Complication of Gadolinium-Enhanced MRI
Journal Watch (General), October 16, 2007; 2007(1016): 2 - 2.
[Full Text]